Charles River Laboratories vs Takeda: CDMO Comparison

How does Charles River Laboratories compare to Takeda for AAV manufacturing?

Side-by-side comparison of Charles River Laboratories and Takeda on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.

Newbury Park, CA · Memphis, TN · Keele, UK · Rockville, MD
Signal Score
91/100
Quality (FDA + GMP)
98/100
FDA inspections
8
— NAI / VAI / OAI
5 / 3 / 0
FDA warning letters
0
EMA GMP certificates (active)
9
MHRA GMP certificates (compliant)
2
Clinical programs (matched)
0
Capacity
Limited
Modalities
CAR-T, Cell Therapy, Gene Editing, Plasmid, AAV, Lentiviral, ADC
Takeda → 81.9
Boston, MA · Zurich, CH
Signal Score
82/100
Quality (FDA + GMP)
100/100
FDA inspections
4
— NAI / VAI / OAI
2 / 2 / 0
FDA warning letters
0
EMA GMP certificates (active)
18
MHRA GMP certificates (compliant)
0
Clinical programs (matched)
100
Capacity
Modalities
AAV, Cell Therapy

Key differences

  • Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
  • Charles River Laboratories maintains 2 MHRA / UK GMP certificates; Takeda does not.
  • Takeda appears as a manufacturing partner on more matched clinical programs (100 vs 0) — a broader sponsor book.

On a 13-modality CDMO landscape, both Charles River Laboratories and Takeda qualify as AAV manufacturers; Charles River Laboratories carries the higher composite Signal Score for AAV programs in this comparison.

What to evaluate for AAV programs

Both Charles River Laboratories and Takeda qualify as AAV CDMOs. When choosing between them for AAV programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.

Platform & scale

Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record.

Capsid quality

Full/empty capsid ratio and aggregate control drive potency and safety. Ask about AUC, anion-exchange separation, and the analytics package for capsid characterization.

Regulatory readiness

For programs heading to BLA, a strong FDA inspection history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.

Capacity & timelines

AAV manufacturing slots can be constrained. Weigh the capacity signal and clinical-program load before committing.

See all AAV CDMOs ranked by Signal Score →

Frequently asked: Charles River Laboratories vs Takeda

How does Charles River Laboratories compare to Takeda for AAV manufacturing?

On CDMO Signal's composite Signal Score, Charles River Laboratories is 91/100 and Takeda is 82/100; Charles River Laboratories has 8 FDA inspections on record vs 4 for Takeda; European coverage is 11 active EMA+MHRA certificates for Charles River Laboratories vs 18 for Takeda. Both are tracked in the CDMO Signal directory as AAV CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.

Which has the stronger FDA inspection record, Charles River Laboratories or Takeda?

Both Charles River Laboratories and Takeda maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. Charles River Laboratories has 8 FDA inspections on record; Takeda has 4.

How do Charles River Laboratories and Takeda compare on European GMP coverage?

Charles River Laboratories holds 9 active EMA GMP certificates and 2 MHRA / UK certificates. Takeda holds 18 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.

Which is more active in clinical-stage manufacturing — Charles River Laboratories or Takeda?

Charles River Laboratories is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Takeda is matched to 100. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.

Which is better for AAV manufacturing — Charles River Laboratories or Takeda?

Both Charles River Laboratories and Takeda are tagged as AAV CDMOs in our directory, so both are credible options for AAV programs. The most important differentiator for AAV selection is typically platform & scale: Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record. Review each CDMO's profile and inspection record before shortlisting.

Evaluating Charles River Laboratories and Takeda for a program?

Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.

Find & compare CDMOs →
Sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.